technetium has been researched along with 3-tyr-octreotide in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Decristoforo, C; Mather, SJ | 1 |
| Babich, JW; Eckelman, WC; Femia, FJ; Hillier, SM; Joyal, JL; Lu, G; Maresca, KP; Marquis, JC; Zimmerman, CN | 1 |
2 other study(ies) available for technetium and 3-tyr-octreotide
| Article | Year |
|---|---|
Technetium-99m somatostatin analogues: effect of labelling methods and peptide sequence.
Topics: Animals; Chelating Agents; Edetic Acid; Isotope Labeling; Male; Neoplasms, Experimental; Octreotide; Radionuclide Imaging; Rats; Rats, Wistar; Somatostatin; Technetium; Tissue Distribution | 1999 |
Novel polar single amino acid chelates for technetium-99m tricarbonyl-based radiopharmaceuticals with enhanced renal clearance: application to octreotide.
Topics: Alkylation; Amino Acids; Animals; Cell Line, Tumor; Chelating Agents; Digestive System; Kidney; Kidney Function Tests; Liver; Metabolic Clearance Rate; Mice; Mice, Nude; Octreotide; Radiopharmaceuticals; Rats; Technetium; Time Factors; Tissue Distribution | 2010 |